Vivos Therapeutics Announces Exciting Q3 2024 Financial Call

Vivos Therapeutics Announces Q3 2024 Financial Results and Call

Vivos Therapeutics, Inc. (NASDAQ: VVOS), a premier medical device and technology company, has exciting news for stakeholders. The company, renowned for its proprietary treatments targeting sleep-related breathing disorders, has announced that it will be releasing its financial results for the third quarter of 2024.

Financial Release Timing

Vivos is set to unveil its financial results after the market closes on a Thursday. This momentous occasion aims to provide investors with insights into the company's recent performance and overall financial health, showcasing its progress in the medical technology sector.

Conference Call Details

As part of the announcement, Vivos management will host a conference call at 5:00 p.m. Eastern Time. Investors and interested parties can join this call to gain a comprehensive understanding of the company's performance during the past quarter, highlight growth strategies, and discuss recent accomplishments in the realm of sleep apnea treatment solutions.

How to Join the Call

For those wishing to participate, joining is simple. Domestic callers can dial a specified number, while international participants will have access to a different line. There will also be a recorded replay of this call available shortly after it concludes, ensuring that anyone unable to attend live can still catch up on what they missed. The replay will remain accessible for a limited period following the call, allowing ample opportunity to digest the detailed information shared.

About Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc. (NASDAQ: VVOS) focuses on revolutionizing treatments for various breathing and sleep disorders. The company’s innovative approach targets specific dental and facial anomalies contributing to obstructive sleep apnea (OSA), which affects a significant portion of both adults and children. Vivos is recognized for introducing The Vivos Method, a clinically effective treatment that does not involve surgical or pharmaceutical interventions.

Innovative Treatment Methods

This noninvasive solution has demonstrated effectiveness in over 47,000 patients globally, thanks to trained dentists employing Vivos’ proprietary appliance therapy. This transformative approach not only addresses OSA symptoms but also significantly enhances the quality of life for individuals affected by these disorders.

Benefits of The Vivos Method

The treatment regimens associated with The Vivos Method play a crucial role in altering the shape and position of the jaw, thereby increasing airway space. It has shown promising outcomes in reducing Apnea Hypopnea Index scores, which measure the severity of sleep apnea. By targeting children and adults, Vivos expands its impact on patient care and health outcomes.

Integration with SleepImage Technology

Vivos also markets the SleepImage diagnostic technology, optimizing home sleep testing and allowing for more accessible evaluation of sleep apnea. This commitment to innovation not only improves diagnostic capabilities but also complements Vivos’ extensive treatment options. Their Integrated Practice (VIP) program further supports dentists with valuable training and resources to utilize The Vivos Method effectively.

Future Outlook and Community Impact

The outlook for Vivos Therapeutics remains promising as it continues to form strategic partnerships with sleep treatment providers, enhancing patient access to OSA treatment options, and driving sales of its innovative appliances. Through effective collaborations and community engagement, Vivos is well-positioned to foster awareness and provide relief for those suffering from sleep-related disorders.

Frequently Asked Questions

What are Vivos Therapeutics’ primary products?

Vivos Therapeutics specializes in treatments for sleep-related breathing disorders, including The Vivos Method for obstructive sleep apnea.

How can I attend the financial results call?

You can join the conference call by dialing the provided numbers for domestic and international callers on the specified date.

What is the significance of the Vivos Method?

The Vivos Method is notable for being a noninvasive and cost-effective treatment for obstructive sleep apnea, proving effective for thousands of patients.

How can I learn more about Vivos Therapeutics?

For additional information, visit Vivos Therapeutics’ official website, where you can find resources, news, and insights into their innovative approaches.

What is Vivos’ approach to patient care?

Vivos focuses on empowering dentists through training and resources, fostering effective treatment methods that significantly enhance the quality of life for patients suffering from sleep disorders.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.